Background: A hybrid approach of PCI followed by minimally invasive valve surgery (MIVS), rather than combined median sternotomy CABG and valve surgery, may be preferred for high risk patients with coronary and valvular disease. We therefore evaluated the outcomes of such patients stratified based on their predicted STS mortality risk score. Methods: We retrospectively evaluated all consecutive patients with concomitant coronary artery and valvular heart disease who underwent a hybrid procedure for isolated valve surgery at our institution between February 2009 and July 2013. Results: A total of 185 patients were stratified based on their STS score in to low-(STS < 3%, mean 1.9), intermediate-(STS 3-8%, mean 4.7), and high-risk (STS > 8%, mean 13.1). High-risk patients were older, more were female, and had worse baseline characteristics, including preoperative renal function and ejection fraction (Table) . There was no difference in the PCI characteristics between the groups, and most patients had single vessel PCI (81%) and a drugeluting stent placed (71%). Within a median of 41 days after the PCI, patients underwent first time (85%) or redo (15%) MIVS, and 68% were on dual antiplatelet therapy. Post-operatively, high risk patients required more blood transfusions, had an increased incidence of acute kidney injury, and longer intensive care unit and hospital lengths of stay. The overall 30-day mortality was 4%. The 30-day mortality for the intermediate-and high-risk groups was lower than the predicted STS mortality (3 vs. 4.7% and 11 vs. 13.1%, respectively). Long-term follow-up (mean 15.4 months) was available for 96% of the patients, with an overall all-cause mortality of 13%.
Background: A hybrid approach of PCI followed by minimally invasive valve surgery (MIVS), rather than combined median sternotomy CABG and valve surgery, may be preferred for high risk patients with coronary and valvular disease. We therefore evaluated the outcomes of such patients stratified based on their predicted STS mortality risk score. Methods: We retrospectively evaluated all consecutive patients with concomitant coronary artery and valvular heart disease who underwent a hybrid procedure for isolated valve surgery at our institution between February 2009 and July 2013. Results: A total of 185 patients were stratified based on their STS score in to low-(STS < 3%, mean 1.9), intermediate-(STS 3-8%, mean 4.7), and high-risk (STS > 8%, mean 13.1). High-risk patients were older, more were female, and had worse baseline characteristics, including preoperative renal function and ejection fraction (Table) . There was no difference in the PCI characteristics between the groups, and most patients had single vessel PCI (81%) and a drugeluting stent placed (71%). Within a median of 41 days after the PCI, patients underwent first time (85%) or redo (15%) MIVS, and 68% were on dual antiplatelet therapy. Post-operatively, high risk patients required more blood transfusions, had an increased incidence of acute kidney injury, and longer intensive care unit and hospital lengths of stay. The overall 30-day mortality was 4%. The 30-day mortality for the intermediate-and high-risk groups was lower than the predicted STS mortality (3 vs. 4.7% and 11 vs. 13.1%, respectively). Long-term follow-up (mean 15.4 months) was available for 96% of the patients, with an overall all-cause mortality of 13%. Background: Interventional cardiology is a discipline with growing number of complex procedures, which are exposed to occurrence of many complications. The aim of the study was to assess efficacy and legitimacy of periprocedural checklist in prevention of cardiovascular adverse events, in elective patients undergoing invasive diagnostic and treatment. Methods: 2064 patients directed to treatment in catheterization laboratory between V 2011 to VIII 2012 were analyzed. Patients who were hospitalized without invasive diagnostic and treatment were not included into the study. Patients were divided into two groups: control group-1011 patients with invasive diagnostics and treatment before introduction of periprocedural checklist; intervention group-1053 patients with invasive diagnostics and treatment after introduction of periprocedural checklist. We analyzed studied groups assessing adverse events associated with hospitalization and performed procedures. We also conducted subjective evaluation of checklist by medical staff on the basis of a questionnaire. Results: Baseline characteristic between studied groups was comparable, except higher rate of stable coronary artery disease (50.7 vs 39.6% p¼< 0.001) and and electrophysiology procedures in control group. Implementation of checklist was favorable in case of decreased adverse events (6.8 vs. 3.9% p¼0.004) especially bleedings (2.3 vs 0,3% p< 0.001). Multivariate analysis confirmed that lack of periprocedural checklist during hospitalization was an independent factor associated with higher rate of adverse events (OR¼2.97, 95 CI¼1.60 -5.53, p¼0.001). Subjective evaluation of medical staff opinion showed that implementation of checklist seems to be associated with improved communication skills, work organization, prevented occurrence of medical errors and reduced rate of complications associated with procedures Conclusions: Introduction of periprocedural checklist was associated with significant reduction of adverse events among patients undergoing invasive procedures. It has also positive influence on team communication, organization and quality of treatment, according to medical staff opinion.
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Impact of a Paleolithic Diet on Modifiable Cardiovascular Risk Factors
Deepak Talreja   1   1 Eastern Virginia Medical School/ Sentara, Virginia Beach, VA Background: The paleolithic diet is a nutritional plan consisting primarily of grassfed pasture-raised meats, seafood, vegetables, and secondarily fruits, seeds, eggs, and nuts which mimics the diet consumed by our pre-agricultural, hunter-gatherer ancestors. The diet has been shown to promote weight loss. Compared to other popular diets, the paleolithic diet is relatively balanced in its protein, carbohydrate and fat content. Refined sugars, starches, dairy, and legumes are avoided. Methods: Nondiabetic adults between ages 35 and 85 with one or more risk factors for cardiovascular disease (CVD) were invited to participate in a comprehensive nutrition program and a 60-day diet intervention. An initial health screen was performed to assess weight, blood pressure, fasting glucose, hemoglobin A1c, highly sensitive C-reactive protein, lipids and NMR LipoProfileÒ. Participants maintained a daily food log and meet once weekly with the multi-disciplinary study team to review food logs. At the end of the 60-day intervention and at 6 months, the health screen was repeated and dietary intake logs were evaluated. This group is part of a much larger study (the Va Beach Diet Study with 4 parallel groups -Mediterranean, DASH, Paleo and Dash Diets). We plan to submit the whole as a late breaking trial the entire study to TCT including genetic screening and predictors of diabetes. Results: After 60 days on a paleolithic diet, patients lost on averge 12 lbs (6.7%). There were no changes in LDL-P/LDL-C levels however, VLDL-P and TG levels were significantly reduced. HDL-P was significantly decreased. Blood pressure (both SBP an DBP) significantly improved with the diet over 10 MmHg. Fasting glucose and HbA1c were not significantly changed. See chart Conclusions: Consumption of a paleolithic diet in adults with cardiovascular risk factors promoted weight loss, improved blood pressure and reduced triglycerides and lipoprotein markers associated with insulin resistance. Three other diets were also evaluated in this study: a Mediterranean, DASH diet and Vegan diet. Compared to these three diets, the paleolithic diet produced the greatest triglyceride lowering www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5 :00 PM-7:00 PM JACC Vol 64/11/Suppl B j September 13-17, 2014 j TCT Abstracts/Angioplasty Overview and Outcomes B35
